MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.gene.2026.150201

Медицинская библиотека · Gene · 2026

The VEGF/VEGFR axis in triple-negative breast cancer: a comprehensive review of therapeutic strategies.

Han Muhammed Ihsan, Atalay Pınar, Satir-Basaran Guzide

СтатьяОбзорПеревод в очереди

Аннотация

Triple-negative breast cancer (TNBC) remains one of the most aggressive and therapeutically challenging subtypes of breast cancer due to the absence of estrogen receptor, progesterone receptor, and HER2 expression. As a result, treatment options remain limited, and patient outcomes are often poor. Increasing evidence suggests that tumor angiogenesis plays a critical role in TNBC progression, highlighting the vascular endothelial growth factor receptor (VEGFR) pathway as a potential therapeutic target. This review critically examines the biological role of VEGFR signaling in TNBC and evaluates current therapeutic strategies targeting this pathway. Preclinical studies demonstrate that VEGFR inhibition can suppress tumor growth, angiogenesis, and metastasis. However, clinical trials of anti-angiogenic therapies have produced inconsistent results, raising essential questions regarding patient selection, resistance mechanisms, and therapeutic combinations. We summarize current preclinical and clinical evidence, discuss mechanisms underlying treatment resistance, and evaluate emerging strategies combining VEGFR inhibition with immunotherapy, chemotherapy, and DNA-damage-targeting agents. In addition, we highlight the importance of molecular stratification and biomarker-driven approaches to identify patients most likely to benefit from anti-angiogenic therapy. Overall, while VEGFR-targeted therapy alone has shown limited success, rational combination strategies and improved patient selection may significantly enhance its clinical utility in TNBC.

Для цитирования: Han Muhammed Ihsan, Atalay Pınar, Satir-Basaran Guzide. The VEGF/VEGFR axis in triple-negative breast cancer: a comprehensive review of therapeutic strategies.. Gene. 2026. DOI: 10.1016/j.gene.2026.150201.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.